International Peer-Reviewed JournalOpen AccessISSN 2456-8880
irejournals@gmail.com+91-7433024337

Home / Current Issue / Paper 1707148

1707148 Vol 8 · Issue 4 Download Paper

Sustainable Pharmaceutical Supply Chains: Green Chemistry Approaches to Drug Production and Distribution

Oluchukwu Obinna Ogbuagu Akachukwu Obianuju Mbata Obe Destiny Balogun Olajumoke Oladapo Opeyemi Olaoluawa Ojo Muridzo Muonde

Subject area: Science,Engineering and Technology  ·  Area of research: Pharmaceutical

Abstract

The pharmaceutical industry is under increasing pressure to adopt sustainable practices due to its significant environmental footprint, particularly in the areas of drug production and distribution. This paper explores integrating green chemistry principles into pharmaceutical manufacturing and adopting sustainable supply chain strategies to address these challenges. Green chemistry offers innovative solutions by promoting safer chemical processes, energy efficiency, and waste reduction in drug synthesis. Additionally, eco-friendly packaging, waste reduction strategies, and carbon footprint reduction in logistics are essential for creating a more sustainable pharmaceutical supply chain. However, significant challenges remain, including regulatory hurdles, economic constraints, and resistance to change within the industry. Through an analysis of these factors, this paper highlights the importance of policy interventions, technological advancements, and continued research to overcome barriers and promote the widespread adoption of sustainable practices. The findings indicate that, while progress has been made, further innovation, collaboration, and investment are needed to realize a fully sustainable pharmaceutical supply chain. This paper concludes by offering policy recommendations for greener supply chains and suggesting future research directions to enhance the industry's sustainability through technological advancements in manufacturing, packaging, and logistics.

Keywords

Green Chemistry, Sustainable Supply Chain, Pharmaceutical Manufacturing, Eco-friendly Packaging, Carbon Footprint Reduction, Regulatory Challenges

References

[1] Abaku, E. A., & Odimarha, A. C. (2024). Sustainable supply chain management in the medical industry: a theoretical and practical examination. International Medical Science Research Journal, 4(3), 319-340.

[2] Abbey, A. B. N., Olaleye, I. A., Mokogwu, C., Olufemi-Phillips, A. Q., & Adewale, T. T. (2024). Developing inventory optimization frameworks to minimize economic loss in supply chain management.

[3] Adelodun, M. O., & Anyanwu, E. C. (2024a). A critical review of public health policies for radiation protection and safety.

[4] Adelodun, M. O., & Anyanwu, E. C. (2024b). Environmental and patient safety: Advances in radiological techniques to reduce radiation exposure.

[5] Adelodun, M. O., & Anyanwu, E. C. (2024c). Health Effects of Radiation: An Epidemiological Study on Populations near Nuclear Medicine Facilities. Health, 13(9), 228-239.

[6] Alemede, V., Nwankwo, E. I., Igwama, G. T., Olaboye, J. A., & Anyanwu, E. C. (2024a). Designing state-level policies to support independent pharmacies in providing specialty care services in rural regions. Magna Scientia Advanced Biology and Pharmacy, 13(1), 19-29.

[7] Alemede, V., Nwankwo, E. I., Igwama, G. T., Olaboye, J. A., & Anyanwu, E. C. (2024b). Pharmacists as educators: Enhancing patient understanding and access to specialty medications through community workshops. Magna Scientia Advanced Biology and Pharmacy, 13(1), 1-9.

[8] Alkhouri, M. (2024). Pharmaceutical supply chain–new obstacles and challenges.

[9] Andraos, J., & Matlack, A. S. (2022). Introduction to green chemistry: CRC press.

[10] Arden, N. S., Fisher, A. C., Tyner, K., Lawrence, X. Y., Lee, S. L., & Kopcha, M. (2021). Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future. International Journal of Pharmaceutics, 602, 120554.

[11] Arowoogun, J. O., Ogugua, J. O., Odilibe, I. P., Onwumere, C., Anyanwu, E. C., & Akomolafe, O. (2024). COVID-19 vaccine distribution: A review of strategies in Africa and the USA. World Journal of Advanced Research and Reviews, 21(1), 2729-2739.

[12] Ayo-Farai, O., Ogundairo, O., Maduka, C. P., Okongwu, C. C., Babarinde, A. O., & Sodamade, O. T. (2024). Digital health technologies in chronic disease management: a global perspective. International Journal of Research and Scientific Innovation, 10(12), 533-551.

[13] Banji, A. F., Adekola, A. D., & Dada, S. A. (2024). Telepharmacy models improving chronic disease management in underserved, remote communities. Int Med Sci Res J, 4(11).

[14] Baranes, A. I. (2016). An original institutionalist approach to the structure, conduct, and performance of the pharmaceutical industry: the importance of intangible assets: University of Missouri-Kansas City.

[15] Chaachouay, N., & Zidane, L. (2024). Plant-derived natural products: a source for drug discovery and development. Drugs and Drug Candidates, 3(1), 184-207.

[16] David, B., Wolfender, J.-L., & Dias, D. A. (2015). The pharmaceutical industry and natural products: historical status and new trends. Phytochemistry Reviews, 14, 299-315.

[17] Ding, B. (2018). Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains. Process Safety and Environmental Protection, 119, 115-130.

[18] Drakeford, O. M., & Majebi, N. L. (2024a). Advancing Personalized Autism Interventions in the U.S. A Data Analytics-Driven Conceptual Framework for Social Work. International Journal of Engineering Research and Development, 22(12), 385-391

[19] Drakeford, O. M., & Majebi, N. L. (2024b). Reimagining autism research in the U.S.: A synergistic approach between social work, public health, and data analytic. International Journal of Applied Research in Social Sciences, 6(12), 2916-2928.

[20] Drakeford, O. M., & Majebi, N. L. (2024c). Social work, analytics, and public health in autism: A conceptual approach to enhancing community health outcomes in U.S. underserved areas. International Journal of Frontiers in Science and Technology Research,, 7(2), 100–108.

[21] Drakeford, O. M., & Majebi, N. L. (2024d). Transforming autism care in the U.S.: Conceptualizing a data-driven, social workbased framework for early diagnosis and intervention. International Journal Of Frontiers in Medicine and Surgery Research, 6(2), 117–125 doi:DOI: https://doi.org/10.53294/ijfmsr.2024.6.2.0051

[22] Edoh, N. L., Chigboh, V. M., Zouo, S. J. C., & Olamijuwon, J. (2024). Improving healthcare decision-making with predictive analytics: A conceptual approach to patient risk assessment and care optimization.

[23] Eyo-Udo, N. L., Abbey, A. B. N., & Olaleye, I. A. (2024). Implementing Advanced Analytics for Optimizing Food Supply Chain Logistics and Efficiency. International Journal of Research and Scientific Innovation, 11(12), 861-889.

[24] Fuller, R., Landrigan, P. J., Balakrishnan, K., Bathan, G., Bose-O'Reilly, S., Brauer, M., . . . Corra, L. (2022). Pollution and health: a progress update. The Lancet Planetary Health, 6(6), e535-e547.

[25] G Ferreira, P., D Nicoletti, C., de C da Silva, F., & F Ferreira, V. (2016). Green Synthetic Routes to Pharmaceutical Drugs. Current Green Chemistry, 3(3), 259-276.

[26] Kar, S., Sanderson, H., Roy, K., Benfenati, E., & Leszczynski, J. (2021). Green chemistry in the synthesis of pharmaceuticals. Chemical Reviews, 122(3), 3637-3710.

[27] Kelvin-Agwu, M., Adelodun, M. O., Igwama, G. T., & Anyanwu, E. C. (2024). The role of biomedical engineers in enhancing patient care through efficient equipment management. International Journal Of Frontiers in Medicine and Surgery Research, 6(1), 11-18.

[28] Kelvin-Agwu, M. C., Adelodun, M. O., Igwama, G. T., & Anyanwu, E. C. (2024a). Advancements in biomedical device implants: A comprehensive review of current technologies. Int. J. Front. Med. Surg. Res, 6, 19-28.

[29] Kelvin-Agwu, M. C., Adelodun, M. O., Igwama, G. T., & Anyanwu, E. C. (2024b). Innovative approaches to the maintenance and repair of biomedical devices in resource-limited settings.

[30] Kelvin-Agwu, M. C., Adelodun, M. O., Igwama, G. T., & Anyanwu, E. C. (2024c). Integrating biomedical engineering with open-source telehealth platforms: enhancing remote patient monitoring in global healthcare systems. International Medical Science Research Journal, 4(9).

[31] Krasnodębski, M. (2022). Lost green chemistries: history of forgotten environmental trajectories. Centaurus, 64(2), 509-536.

[32] Kumar, S. A., Ananda Kumar, T. D., Beeraka, N. M., Pujar, G. V., Singh, M., Narayana Akshatha, H. S., & Bhagyalalitha, M. (2022). Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry. Future Medicinal Chemistry, 14(4), 245-270.

[33] Llevot, A., & Meier, M. A. (2016). Renewability–a principle of utmost importance! Green Chemistry, 18(18), 4800-4803.

[34] Low, Y. S., Halim, I., Adhitya, A., Chew, W., & Sharratt, P. (2016). Systematic framework for design of environmentally sustainable pharmaceutical supply chain network. Journal of Pharmaceutical Innovation, 11, 250-263.

[35] Majebi, N. L., Adelodun, M. O., & Anyanwu, E. C. (2024). Integrating trauma-informed practices in US educational systems: Addressing behavioral challenges in underserved communities.

[36] Najmi, A., Javed, S. A., Al Bratty, M., & Alhazmi, H. A. (2022). Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents. Molecules, 27(2), 349.

[37] Nižetić, S., Djilali, N., Papadopoulos, A., & Rodrigues, J. J. (2019). Smart technologies for promotion of energy efficiency, utilization of sustainable resources and waste management. Journal of Cleaner Production, 231, 565-591.

[38] Ogbeta, C. P., Mbata, A. O., & Katas, K. U. (2024). Developing Drug Formularies and Advocating for Biotechnology Growth: Pioneering Healthcare Innovation in Emerging Economies. Quality assurance, 30.

[39] Ogbonna, P. C., Oparaocha, E. T., Anyanwu, E. C., & Innocent, D. C. (2024). Physico-chemical analysis of hospital water in selected secondary health facilities in Bayelsa state, Nigeria.

[40] Olaleye, I. A., Mokogwu, C., Olufemi-Phillips, A. Q., & Adewale, T. T. (2024). Real-time inventory optimization in dynamic supply chains using advanced artificial intelligence. Journal name if available.

[41] Peake, B. M., Braund, R., Tong, A., & Tremblay, L. A. (2015). The Life-cycle of Pharmaceuticals in the Environment: Elsevier.

[42] Quiñones, O. G., & Pierre, M. B. (2019). Cutaneous application of celecoxib for inflammatory and cancer diseases. Current Cancer Drug Targets, 19(1), 5-16.

[43] Rame, R., Purwanto, P., & Sudarno, S. (2024). Industry 5.0 and sustainability: An overview of emerging trends and challenges for a green future. Innovation and Green Development, 3(4), 100173.

[44] Sheldon, R. A. (2018). Metrics of green chemistry and sustainability: past, present, and future. ACS Sustainable Chemistry & Engineering, 6(1), 32-48.

[45] Sherman, J. D., Thiel, C., MacNeill, A., Eckelman, M. J., Dubrow, R., Hopf, H., . . . Forbes, M. (2020). The green print: advancement of environmental sustainability in healthcare. Resources, Conservation and Recycling, 161, 104882.

[46] Singh, R. K., Kumar, R., & Kumar, P. (2016). Strategic issues in pharmaceutical supply chains: a review. International Journal of Pharmaceutical and Healthcare Marketing, 10(3), 234-257.

[47] Tien, N. H., Anh, D. B. H., & Thuc, T. D. (2019). Global supply chain and logistics management. In: Academic Publications, Dehli.

[48] Veleva, V. R., Cue Jr, B. W., & Todorova, S. (2018). Benchmarking green chemistry adoption by the global pharmaceutical supply chain. ACS Sustainable Chemistry & Engineering, 6(1), 2-14.

[49] Venkatesh, V., Kang, K., Wang, B., Zhong, R. Y., & Zhang, A. (2020). System architecture for blockchain based transparency of supply chain social sustainability. Robotics and Computer-Integrated Manufacturing, 63, 101896.

[50] Wingate, G. (2016). Pharmaceutical computer systems validation: quality assurance, risk management and regulatory compliance.

How to cite this paper

Oluchukwu Obinna Ogbuagu, Akachukwu Obianuju Mbata, Obe Destiny Balogun, Olajumoke Oladapo, Opeyemi Olaoluawa Ojo; Muridzo Muonde "Sustainable Pharmaceutical Supply Chains: Green Chemistry Approaches to Drug Production and Distribution" Iconic Research And Engineering Journals Volume 8 Issue 4 2024 Page 761-775
Oluchukwu Obinna Ogbuagu, Akachukwu Obianuju Mbata, Obe Destiny Balogun, Olajumoke Oladapo, Opeyemi Olaoluawa Ojo; Muridzo Muonde "Sustainable Pharmaceutical Supply Chains: Green Chemistry Approaches to Drug Production and Distribution" Iconic Research And Engineering Journals, vol. 8, no. 4, Oct. 2024
Oluchukwu Obinna Ogbuagu, Akachukwu Obianuju Mbata, Obe Destiny Balogun, Olajumoke Oladapo, Opeyemi Olaoluawa Ojo; Muridzo Muonde (2024). Sustainable Pharmaceutical Supply Chains: Green Chemistry Approaches to Drug Production and Distribution. Iconic Research And Engineering Journals, 8(4).
Oluchukwu Obinna Ogbuagu, Akachukwu Obianuju Mbata, Obe Destiny Balogun, Olajumoke Oladapo, Opeyemi Olaoluawa Ojo; Muridzo Muonde "Sustainable Pharmaceutical Supply Chains: Green Chemistry Approaches to Drug Production and Distribution" Iconic Research And Engineering Journals, vol. 8, no. 4, Oct. 2024.
@article{1707148,
      author = {Oluchukwu Obinna Ogbuagu, Akachukwu Obianuju Mbata, Obe Destiny Balogun, Olajumoke Oladapo, Opeyemi Olaoluawa Ojo; Muridzo Muonde},
      title = {Sustainable Pharmaceutical Supply Chains: Green Chemistry Approaches to Drug Production and Distribution},
      journal = {Iconic Research And Engineering Journals},
      year = {2024},
      volume = {8},
      number = {4},
      pages = {761-775},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1707148.pdf},
      abstract = {The pharmaceutical industry is under increasing pressure to adopt sustainable practices due to its significant environmental footprint, particularly in the areas of drug production and distribution. This paper explores integrating green chemistry principles into pharmaceutical manufacturing and adopting sustainable supply chain strategies to address these challenges. Green chemistry offers innovative solutions by promoting safer chemical processes, energy efficiency, and waste reduction in drug synthesis. Additionally, eco-friendly packaging, waste reduction strategies, and carbon footprint reduction in logistics are essential for creating a more sustainable pharmaceutical supply chain. However, significant challenges remain, including regulatory hurdles, economic constraints, and resistance to change within the industry. Through an analysis of these factors, this paper highlights the importance of policy interventions, technological advancements, and continued research to overcome barriers and promote the widespread adoption of sustainable practices. The findings indicate that, while progress has been made, further innovation, collaboration, and investment are needed to realize a fully sustainable pharmaceutical supply chain. This paper concludes by offering policy recommendations for greener supply chains and suggesting future research directions to enhance the industry's sustainability through technological advancements in manufacturing, packaging, and logistics.},
      keywords = {Green Chemistry, Sustainable Supply Chain, Pharmaceutical Manufacturing, Eco-friendly Packaging, Carbon Footprint Reduction, Regulatory Challenges},
      month = {October},
  }